Search

Omnicell Inc

Закрыт

СекторЗдравоохранение

36.18 0.67

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

35.76

Макс.

37.2

Ключевые показатели

By Trading Economics

Доход

13M

24M

Продажи

2.3M

312M

P/E

Средняя по отрасли

44.482

57.371

Прибыль на акцию

0.7

Рентабельность продаж

7.78

Сотрудники

3,485

EBITDA

-22M

14M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+52.65% upside

Дивиденды

By Acuity

Следующий отчет о доходах

29 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-248M

1.6B

Предыдущая цена открытия

35.51

Предыдущая цена закрытия

36.18

Новостные настроения

By Acuity

3%

97%

2 / 340 Рейтинг в Healthcare

Omnicell Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 авг. 2026 г., 22:51 UTC

Omnicell Inc shares are lower in after-market hours, reflecting broader negative sentiment amid rising sovereign bond yields and inflation concerns.

17 авг. 2026 г., 23:36 UTC

Omnicell shares are higher in after-market trading, gaining after closing up on Monday. The broader market showed mixed performance amid rising crude oil prices.

14 авг. 2026 г., 23:01 UTC

Omnicell Inc shares rose in after-market trading, recovering from an early low. The stock remains below its 20-day moving average.

12 авг. 2026 г., 19:41 UTC

News

Omnicell shares are higher amid positive sentiment ahead of management's meetings with KeyBanc in Philadelphia and New York this month.

11 авг. 2026 г., 22:16 UTC

Omnicell Inc shares are higher in after-market trading, with no specific news identified. Market focus remains on inflation data and Federal Reserve interest rate hikes.

10 авг. 2026 г., 19:16 UTC

News

Omnicell Inc reported second-quarter revenue of $312.21 million and upgraded its guidance, contributing to shares trading higher since Friday's close.

7 авг. 2026 г., 23:16 UTC

Omnicell Inc shares are rising in after-market trading, reflecting broader market dynamics following a disappointing jobs report that reduced interest rate hike expectations.

6 авг. 2026 г., 23:21 UTC

Omnicell Inc's shares are higher in after-market trading, showing strength following Thursday's close amid broader market dynamics and upcoming economic data.

5 авг. 2026 г., 22:02 UTC

Omnicell Inc shares are higher in after-market trading, continuing an earlier session advance. The stock remains below its 20-day moving average and one-month range.

4 авг. 2026 г., 20:07 UTC

Omnicell Inc. shares are trading lower, reflecting ongoing weakness and remaining significantly below the 20-day moving average. The stock peaked earlier in the session.

3 авг. 2026 г., 23:02 UTC

Omnicell Inc shares are lower in after-market trading, following a weak session and remaining below their 20-day moving average. No specific news was identified.

31 июл. 2026 г., 22:01 UTC

Omnicell Inc. shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down and remaining below the 20-day moving average.

30 июл. 2026 г., 23:21 UTC

Omnicell Inc. shares moved lower in after-market trading amid notable volatility and broader market dynamics, including mixed Asian market performance and geopolitical tensions.

29 июл. 2026 г., 18:26 UTC

News

Omnicell Inc shares are higher as analysts maintain a positive outlook ahead of Thursday's Q2 earnings announcement, following a strong prior quarter with $309.9 million in revenue.

28 июл. 2026 г., 20:51 UTC

Omnicell Inc shares are lower in after-market hours. The decline comes amid no specific news and follows three sessions of higher closes.

27 июл. 2026 г., 19:46 UTC

Omnicell Inc shares are higher today, supported by falling crude oil prices and easing geopolitical tensions following U.S. diplomatic efforts with Iran.

24 июл. 2026 г., 20:13 UTC

Omnicell Inc shares are lower in after-market hours. No specific company news was identified to explain the decline amid recent market volatility.

22 июл. 2026 г., 18:46 UTC

News

Omnicell Inc is trading lower amid negative sentiment and concerns over financial performance. The stock's current price is $41.95.

21 июл. 2026 г., 19:51 UTC

Omnicell Inc's shares are lower during Tuesday's session, reversing from a recent trend of higher daily closes. No specific news was identified for the decline.

20 июл. 2026 г., 19:36 UTC

News

Omnicell Inc shares are lower amid a report suggesting the stock is one to avoid, citing modest revenue growth and declining earnings per share. Current valuation is $45.39.

Сравнение c конкурентами

Изменение цены

Omnicell Inc Прогноз

Целевая цена

By TipRanks

52.65% рост

Прогноз на 12 месяцев

Средняя 55 USD  52.65%

Максимум 65 USD

Минимум 45 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Omnicell Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

6 ratings

6

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

2 / 340Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat